Merit Medical Systems, Inc. (NASDAQ:MMSI) Stock Has Average Price Target of $100.00 According to Analysts

Shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) have received a consensus rating of “Moderate Buy” from the twelve brokerages that are covering the firm, Marketbeat.com reports. Three equities research analysts have rated the stock with a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the company. The average twelve-month price objective among brokerages that have issued a report on the stock in the last year is $100.00.

Several research firms recently issued reports on MMSI. Raymond James Financial restated an “outperform” rating and issued a $100.00 price target on shares of Merit Medical Systems in a research note on Friday, July 31st. Zacks Research raised Merit Medical Systems from a “hold” rating to a “strong-buy” rating in a report on Tuesday, August 25th. Bank of America boosted their target price on shares of Merit Medical Systems from $92.00 to $97.00 and gave the company a “neutral” rating in a research report on Thursday, August 13th. Wells Fargo & Company upped their price target on shares of Merit Medical Systems from $74.00 to $83.00 and gave the company an “equal weight” rating in a research note on Friday, July 31st. Finally, Canaccord Genuity Group raised their price target on shares of Merit Medical Systems from $85.00 to $94.00 and gave the stock a “buy” rating in a research report on Friday, July 31st.

Merit Medical Systems Trading Down 0.1%

MMSI stock opened at $86.15 on Friday. Merit Medical Systems has a one year low of $59.74 and a one year high of $94.75. The stock has a market cap of $5.14 billion, a price-to-earnings ratio of 35.60, a price-to-earnings-growth ratio of 2.15 and a beta of 0.51. The company has a fifty day moving average price of $87.38 and a two-hundred day moving average price of $74.58. The company has a debt-to-equity ratio of 0.44, a current ratio of 4.20 and a quick ratio of 2.79.

Merit Medical Systems (NASDAQ:MMSI) last announced its earnings results on Thursday, July 30th. The medical instruments supplier reported $1.19 EPS for the quarter, topping the consensus estimate of $0.96 by $0.23. Merit Medical Systems had a net margin of 9.22% and a return on equity of 13.75%. The business had revenue of $418.84 million during the quarter, compared to the consensus estimate of $405.25 million. During the same quarter in the previous year, the firm posted $1.01 EPS. Merit Medical Systems’s revenue was up 9.5% compared to the same quarter last year. Merit Medical Systems has set its FY 2026 guidance at 4.250-4.350 EPS. Equities analysts anticipate that Merit Medical Systems will post 3.84 EPS for the current year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in the business. QRG Capital Management Inc. grew its position in Merit Medical Systems by 10.9% during the second quarter. QRG Capital Management Inc. now owns 9,305 shares of the medical instruments supplier’s stock worth $645,000 after buying an additional 917 shares in the last quarter. Talon Private Wealth LLC grew its holdings in shares of Merit Medical Systems by 36.4% during the 2nd quarter. Talon Private Wealth LLC now owns 11,727 shares of the medical instruments supplier’s stock worth $813,000 after purchasing an additional 3,130 shares in the last quarter. Sequoia Financial Advisors LLC acquired a new stake in shares of Merit Medical Systems during the 2nd quarter worth $282,000. Van Hulzen Asset Management LLC increased its position in shares of Merit Medical Systems by 25.0% in the second quarter. Van Hulzen Asset Management LLC now owns 28,877 shares of the medical instruments supplier’s stock worth $2,002,000 after purchasing an additional 5,778 shares during the period. Finally, Integrated Wealth Concepts LLC acquired a new position in Merit Medical Systems in the second quarter valued at about $199,000. Institutional investors and hedge funds own 99.66% of the company’s stock.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc is a medical device company that develops, manufactures and markets disposable products used in interventional, diagnostic and therapeutic procedures. Its devices are designed for use by healthcare professionals in areas including cardiology, radiology, oncology, vascular intervention, gastroenterology and other specialty fields.

The company’s product portfolio includes devices for accessing the vasculature, controlling and managing fluids, performing biopsies, treating peripheral vascular disease, delivering embolic therapies, and supporting drainage and intervention procedures.